$100.72
0.150.15%
À la fermeture: -
$101.39
0.670.67%
Après les heures de négociation: Oct 31, 7:37 PM EDT
Comments
Loading...
Orientation et prévision
Boston Scientific publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/2025 | BSX | Boston Scientific | Q4 | 2025 | $0.77 | $0.79 | $0.71 | $5.22B | $5.31B | $4.97B | |
10/22/2025 | BSX | Boston Scientific | FY | 2025 | $3.02 | $3.04 | $2.98 | $20.10B | $20.10B | $19.87B | |
07/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.95 | $2.99 | $2.91 | $19.76B | $19.93B | $19.48B | |
07/23/2025 | BSX | Boston Scientific | Q3 | 2025 | $0.70 | $0.72 | $0.71 | $4.92B | $5.01B | $4.87B | |
05/28/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.88 | $19.26B | $19.59B | $19.48B | |
05/28/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.89B | |
04/23/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.78B | |
04/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.86 | $19.26B | $19.59B | $19.13B | |
02/05/2025 | BSX | Boston Scientific | Q1 | 2025 | $0.66 | $0.68 | $0.65 | $4.51B | $4.59B | $4.45B | |
02/05/2025 | BSX | Boston Scientific | FY | 2025 | $2.80 | $2.87 | $2.81 | $18.84B | $19.18B | $18.79B | |
10/23/2024 | BSX | Boston Scientific | Q4 | 2024 | $0.64 | $0.66 | $0.64 | $4.34B | $4.41B | $4.28B | |
10/23/2024 | BSX | Boston Scientific | FY | 2024 | $2.45 | $2.47 | $2.41 | $16.59B | $16.59B | $16.29B | |
07/24/2024 | BSX | Boston Scientific | Q3 | 2024 | $0.57 | $0.59 | $0.57 | $3.99B | $4.06B | $3.96B | |
07/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.38 | $2.42 | $2.33 | $16.16B | $16.30B | $16.00B | |
04/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.29 | $2.34 | $2.25 | $15.81B | $16.09B | $15.58B | |
04/24/2024 | BSX | Boston Scientific | Q2 | 2024 | $0.57 | $0.59 | $0.56 | $3.98B | $4.05B | $3.93B | |
01/31/2024 | BSX | Boston Scientific | FY | 2024 | $2.23 | $2.27 | $2.24 | $15.45B | $15.59B | $15.35B | |
01/31/2024 | BSX | Boston Scientific | Q1 | 2024 | $0.50 | $0.52 | $0.52 | $3.64B | $3.71B | $3.67B | |
10/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.99 | $2.02 | $2.00 | $14.08B | $14.08B | $14.09B | |
10/26/2023 | BSX | Boston Scientific | Q4 | 2023 | $0.49 | $0.52 | $0.52 | $3.53B | $3.60B | $3.63B | |
09/20/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.99 | $14.00B | $14.00B | $14.09B | |
07/27/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.95 | $14.01B | $14.14B | $13.95B | |
07/27/2023 | BSX | Boston Scientific | Q3 | 2023 | $0.46 | $0.48 | $0.48 | $3.44B | $3.50B | $3.44B | |
04/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.90 | $1.96 | $1.91 | $13.76B | $14.01B | $13.55B | |
04/26/2023 | BSX | Boston Scientific | Q2 | 2023 | $0.48 | $0.50 | $0.48 | $3.46B | $3.52B | $3.44B | |
02/01/2023 | BSX | Boston Scientific | FY | 2023 | $1.86 | $1.93 | $1.93 | $13.32B | $13.57B | $13.46B | |
02/01/2023 | BSX | Boston Scientific | Q1 | 2023 | $0.42 | $0.44 | $0.44 | $3.12B | $3.18B | $3.17B | |
10/26/2022 | BSX | Boston Scientific | FY | 2022 | $1.71 | $1.74 | $1.76 | $12.66B | $12.66B | $12.71B | |
10/26/2022 | BSX | Boston Scientific | Q4 | 2022 | $0.45 | $0.48 | $0.49 | $3.19B | $3.25B | $3.32B | |
07/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.77 | $1.76 | $12.66B | $12.78B | $12.82B | |
07/27/2022 | BSX | Boston Scientific | Q3 | 2022 | $0.43 | $0.45 | $0.45 | $3.11B | $3.17B | $3.20B | |
04/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.79 | $1.77 | $12.72B | $12.96B | $12.84B | |
04/27/2022 | BSX | Boston Scientific | Q2 | 2022 | $0.41 | $0.43 | $0.44 | $3.17B | $3.26B | $3.27B | |
02/02/2022 | BSX | Boston Scientific | FY | 2022 | $1.73 | $1.79 | $1.87 | $12.60B | $12.84B | $12.93B | |
02/02/2022 | BSX | Boston Scientific | Q1 | 2022 | $0.38 | $0.40 | $0.41 | $2.89B | $2.97B | $3.03B | |
10/27/2021 | BSX | Boston Scientific | Q4 | 2021 | $0.43 | $0.45 | $0.44 | $3.06B | $3.17B | $3.20B | |
10/27/2021 | BSX | Boston Scientific | FY | 2021 | $1.60 | $1.62 | $1.61 | $11.80B | $11.90B | $12.00B | |
09/22/2021 | BSX | Boston Scientific | FY | 2021 | $1.58 | $1.62 | $1.61 | $12.00B | $12.00B | $12.01B | |
07/27/2021 | BSX | Boston Scientific | Q3 | 2021 | $0.39 | $0.41 | $0.40 | $2.98B | $3.03B | $2.97B | |
07/27/2021 | BSX | Boston Scientific | FY | 2021 | $1.58 | $1.62 | $1.58 | $11.99B | $12.09B | $11.75B | |
04/28/2021 | BSX | Boston Scientific | Q2 | 2021 | $0.36 | $0.38 | $0.35 | $2.92B | $3.00B | $2.76B | |
04/28/2021 | BSX | Boston Scientific | FY | 2021 | $1.53 | $1.60 | $1.54 | $11.50B | $11.80B | $11.43B | |
02/03/2021 | BSX | Boston Scientific | Q1 | 2021 | $0.28 | $0.34 | $0.35 | $2.54B | $2.70B | $2.73B | |
02/03/2021 | BSX | Boston Scientific | FY | 2021 | $1.50 | $1.60 | $1.62 | $11.20B | $11.80B | $11.53B |
FAQ
Quelles sont les dernières directives pour Boston Scientific (BSX) ?
Les dernières prévisions pour Boston Scientific (BSX) ont été communiquées le octobre 22, 2025 pour Q4 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $0.77 à $0.79, par rapport à un BPA estimé de $0.71. De plus, Boston Scientific a prévu un chiffre d'affaires entre $5.22B et $5.31B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.